Literature DB >> 12370333

Cutting edge: suppression of T cell chemotaxis by sphingosine 1-phosphate.

Markus Graeler1, Geetha Shankar, Edward J Goetzl.   

Abstract

Murine CD4 and CD8 T cells express predominantly types 1 and 4 sphingosine 1-phosphate (S1P) G protein-coupled receptors (designated S1P1 and S1P4 or previously endothelial differentiation gene-encoded 1 and 6) for S1P, which has a normal plasma concentration of 0.1-1 microM. S1P now is shown to enhance chemotaxis of CD4 T cells to CCL-21 and CCL-5 by up to 2.5-fold at 10 nM to 0.1 microM, whereas 0.3-3 microM S1P inhibits this chemotaxis by up to 70%. Chemotaxis of S1P(1), but not S1P(4), transfectants to CXCL1 and CXCL4 was similarly affected by S1P. Activation of CD4 T cells, which decreases S1P receptor expression, suppressed effects of S1P on chemotaxis. Pretreatment of labeled CD4 T cells with S1P before reintroduction into mice inhibited by a maximum of 75% their migration into chemokine-challenged s.c. air pouches. The S1P-S1P(1) receptor axis thus controls recruitment of naive T cells by maintaining their response threshold to diverse lymphotactic factors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370333     DOI: 10.4049/jimmunol.169.8.4084

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  40 in total

1.  Rapid induction of medullary thymocyte phenotypic maturation and egress inhibition by nanomolar sphingosine 1-phosphate receptor agonist.

Authors:  Hugh Rosen; Christopher Alfonso; Charles D Surh; Michael G McHeyzer-Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-03       Impact factor: 11.205

Review 2.  Therapeutic antibodies directed at G protein-coupled receptors.

Authors:  Catherine J Hutchings; Markus Koglin; Fiona H Marshall
Journal:  MAbs       Date:  2010-11-01       Impact factor: 5.857

3.  Increased serum concentration of sphingosine-1-phosphate in juvenile-onset systemic lupus erythematosus.

Authors:  L Watson; K Tullus; S D Marks; R C L Holt; C Pilkington; M W Beresford
Journal:  J Clin Immunol       Date:  2012-05-31       Impact factor: 8.317

4.  FTY720, a sphingosine-1 phosphate receptor modulator, improves liver fibrosis in a mouse model by impairing the motility of bone marrow-derived mesenchymal stem cells.

Authors:  Yaxian Kong; Hong Wang; Shuling Wang; Na Tang
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

5.  B lymphocytes exit lymph nodes through cortical lymphatic sinusoids by a mechanism independent of sphingosine-1-phosphate-mediated chemotaxis.

Authors:  Rajesh K Sinha; Chung Park; Il-Young Hwang; Michael D Davis; John H Kehrl
Journal:  Immunity       Date:  2009-02-19       Impact factor: 31.745

6.  Sphingosine-1-phosphate receptor 1 agonism attenuates lung ischemia-reperfusion injury.

Authors:  Matthew L Stone; Ashish K Sharma; Yunge Zhao; Eric J Charles; Mary E Huerter; William F Johnston; Irving L Kron; Kevin R Lynch; Victor E Laubach
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-04-24       Impact factor: 5.464

7.  Human immunodeficiency virus type 1 gp120 reprogramming of CD4+ T-cell migration provides a mechanism for lymphadenopathy.

Authors:  Daniel S Green; David M Center; William W Cruikshank
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

8.  PAM mediates sustained inhibition of cAMP signaling by sphingosine-1-phosphate.

Authors:  Sandra C Pierre; Julia Häusler; Kerstin Birod; Gerd Geisslinger; Klaus Scholich
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

Review 9.  Sphingosine 1-phosphate and its G protein-coupled receptors constitute a multifunctional immunoregulatory system.

Authors:  Edward J Goetzl; Wengang Wang; Christine McGiffert; Mei-Chuan Huang; Markus H Gräler
Journal:  J Cell Biochem       Date:  2004-08-15       Impact factor: 4.429

10.  Human eosinophil chemotaxis and selective in vivo recruitment by sphingosine 1-phosphate.

Authors:  Fiorentina Roviezzo; Francesco Del Galdo; Gianfranco Abbate; Mariarosaria Bucci; Bruno D'Agostino; Edson Antunes; Gianfranco De Dominicis; Luca Parente; Francesco Rossi; Giuseppe Cirino; Raffaele De Palma
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.